Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PRIORITI-MTF Study- Testing Patient Response to the IDEO

NCT: NCT02158884 · COMPLETED

NCT IDNCT02158884
StatusCOMPLETED
Start Date2014-06
Completion2018-04
SponsorMajor Extremity Trauma Research Consortium (OTHER)
First posted
Last updated

Brief Summary

The goal of the PRIORITI-MTF study is to help determine whether a new type of custom designed brace, called the IDEO ™ along with a physical therapy program, called Return to Run, improves physical function. This brace was developed for wounded warriors who wanted to return to an active lifestyle. The primary objective of this study is to examine the benefits (and cost-benefits) of an integrated orthotic and rehabilitation program that incorporates the Intrepid Dynamic Exoskeletal Orthosis (IDEO) and the Return to Run (RTR) physical therapy regimen, but designed for scalability in the broader military environment (i.e. beyond San Antonio Military Medical Center where the program was developed)

Frequently Asked Questions

What is PRIORITI-MTF Study- Testing Patient Response to the IDEO?

PRIORITI-MTF Study- Testing Patient Response to the IDEO is a clinical trial registered under NCT02158884. Current status: COMPLETED.

What is the status of NCT02158884?

The current status of NCT02158884 (PRIORITI-MTF Study- Testing Patient Response to the IDEO) is: COMPLETED.

When did PRIORITI-MTF Study- Testing Patient Response to the IDEO start?

PRIORITI-MTF Study- Testing Patient Response to the IDEO started on 2014-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.